The drug had no effect on blood pressure and only raised heart rates slightly.
The pharmaceutical company, Neurosearch, hopes to begin clinical trials of the drug next year.
That's the last stage of human testing before a company can seek regulatory approval for a drug.
- Get more L.A. breaking news, weather, traffic and sports
- Have a news tip? Send your tips, video, or pictures